Is Japan about to switch on medicines reclassification?
- At: Amsterdam (the Netherlands) (2012)
- Type: Poster
- By: GAULD, Natalie (University of Auckland, General Practice and Primary Healthcare, Auckland, New Zealand)
- Co-author(s): Kurosawa, N. (Hokkaido Pharmaceutical University, Sapporo, Japan)
Kelly, F. (University of Auckland, Auckland, New Zealand)
Emmerton, L. (Curtin University, Perth, Australia)
Buetow, S. (University of Auckland, Auckland, New Zealand)
Background: Prescription to non-prescription reclassification (‘switch’) might help to relieve pressure on health funding from Japan’s aging population. Reclassification has been proposed for medicines including ACE inhibitors and diabetes agents.Aims: To ascertain barriers and enablers for medicines reclassification in Japan.Methods:.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.